Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of June 6, 2025 • 11:01 AM ET

Date/Time Source News Release
05/13/2025 04:05 PM EDT PR Newswire DURECT Corporation Reports First Quarter 2025 Financial Results and Provides Business Update
03/26/2025 04:05 PM EDT PR Newswire DURECT Corporation Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
03/19/2025 04:30 PM EDT PR Newswire DURECT Corporation to Announce Fourth Quarter and Full Year 2024 Financial Results and Provide a Business Update
02/04/2025 07:30 AM EST PR Newswire DURECT Corporation to Present at Oppenheimer 35th Annual Healthcare Life Sciences Conference
01/28/2025 10:09 AM EST PR Newswire DURECT Corporation Announces Publication of Larsucosterol Phase 2b Results in NEJM Evidence
11/25/2024 06:00 AM EST PR Newswire DURECT Corporation Announces Sale of ALZET® Product Line to Lafayette Instrument Co. for $17.5 Million
11/13/2024 04:01 PM EST PR Newswire DURECT Corporation Reports Third Quarter 2024 Financial Results and Provides Business Update
11/06/2024 04:45 PM EST PR Newswire DURECT Corporation to Announce Third Quarter 2024 Financial Results and Provide a Business Update
10/17/2024 08:30 AM EDT PR Newswire DURECT Corporation to Present Data on Larsucosterol at The Liver Meeting 2024
09/25/2024 08:00 AM EDT PR Newswire DURECT Corporation Announces Phase 3 Registrational Trial Design for Larsucosterol in Alcohol-associated Hepatitis
Page

Additional News

As of June 6, 2025 • 11:01 AM ET

Date/Time Source News Release
05/13/2025 05:24 PM EDT SeekingAlpha DURECT GAAP EPS of -$0.13 misses by $0.01, revenue of $0.32M beats by $0.03M
05/12/2025 07:00 AM EDT US Earnings Reports Expected US Company Earnings on Monday, May 12th, 2025
05/12/2025 05:30 AM EDT US Earnings Reports Expected earnings - DURECT Corporation
05/07/2025 06:25 PM EDT Zacks Catalyst Pharmaceutical (CPRX) Q1 Earnings and Revenues Top Estimates
03/26/2025 08:04 PM EDT SeekingAlpha DURECT outlines $20M Phase 3 trial for larsucosterol in alcohol-associated hepatitis
03/26/2025 08:04 PM EDT SeekingAlpha DURECT Corporation (DRRX) Q4 2024 Earnings Call Transcript
03/26/2025 05:20 PM EDT Zacks Durect (DRRX) Reports Q4 Loss, Lags Revenue Estimates
03/26/2025 04:08 PM EDT SeekingAlpha DURECT GAAP EPS of $0.24, revenue of $0.45M
03/26/2025 10:00 AM EDT SeekingAlpha Here are the major earnings after the close today
03/26/2025 07:00 AM EDT US Earnings Reports Expected US Company Earnings on Wednesday, March 26th, 2025
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.